BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36645114)

  • 81. Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System.
    Schelb P; Tavakoli AA; Tubtawee T; Hielscher T; Radtke JP; Görtz M; Schütz V; Kuder TA; Schimmöller L; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
    Rofo; 2021 May; 193(5):559-573. PubMed ID: 33212541
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
    Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
    BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fast CSF MRI for brain segmentation; Cross-validation by comparison with 3D T1-based brain segmentation methods.
    van der Kleij LA; de Bresser J; Hendrikse J; Siero JCW; Petersen ET; De Vis JB
    PLoS One; 2018; 13(4):e0196119. PubMed ID: 29672584
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A MRI-based radiomics nomogram for evaluation of renal function in ADPKD.
    Li X; Liu Q; Xu J; Huang C; Hua Q; Wang H; Ma T; Huang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1385-1395. PubMed ID: 35152314
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
    Kim K; Trott JF; Gao G; Chapman A; Weiss RH
    BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Calculation of Kidney Volumes with Magnetic Resonance in Patients with Autosomal Dominant Polycystic Kidney Disease: Comparison between Methods.
    Di Pietro S; Torcitto AG; Marcantoni C; Giordano G; Campisi C; Failla G; Saporito L; Giunta R; Veroux M; Foti PV; Palmucci S; Basile A
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066815
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
    Higashihara E; Torres VE; Chapman AB; Grantham JJ; Bae K; Watnick TJ; Horie S; Nutahara K; Ouyang J; Krasa HB; Czerwiec FS;
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2499-507. PubMed ID: 21903984
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Deep Learning-Based Total Kidney Volume Segmentation in Autosomal Dominant Polycystic Kidney Disease Using Attention, Cosine Loss, and Sharpness Aware Minimization.
    Raj A; Tollens F; Hansen L; Golla AK; Schad LR; Nörenberg D; Zöllner FG
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626314
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Spleen phenotype in autosomal dominant polycystic kidney disease.
    Yin X; Prince WK; Blumenfeld JD; Zhang W; Donahue S; Bobb WO; Rennert H; Askin G; Barash I; Prince MR
    Clin Radiol; 2019 Dec; 74(12):975.e17-975.e24. PubMed ID: 31563290
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease.
    Liebau MC; Serra AL
    Pediatr Nephrol; 2013 Sep; 28(9):1771-83. PubMed ID: 23239392
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Does hydration status influence kidney volume in autosomal dominant polycystic kidney disease?
    Naver SV; Jensen AM; Egfjord M; Ørskov B; Østergaard MGØ; Blankholm AD; Fallentin E; Pedersen M; Jensen JD
    Clin Nephrol; 2023 Nov; 100(5):195-201. PubMed ID: 37779450
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MRI in autosomal dominant polycystic kidney disease.
    Zhang W; Blumenfeld JD; Prince MR
    J Magn Reson Imaging; 2019 Jul; 50(1):41-51. PubMed ID: 30637853
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of spoiled gradient echo and steady-state free-precession imaging for native myocardial T1 mapping using the slice-interleaved T1 mapping (STONE) sequence.
    Jang J; Bellm S; Roujol S; Basha TA; Nezafat M; Kato S; Weingärtner S; Nezafat R
    NMR Biomed; 2016 Oct; 29(10):1486-96. PubMed ID: 27658506
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of Kidney transplantation on cyst growth in autosomal dominant polycystic kidney disease.
    Gaytan-Arocha JE; Pérez-Segovia A; Reul-Linares E; Hernández-Paredes EN; Chapa-Ibargüengoitia M; Correa-Rotter R; Morales-Buenrostro LE; Ramirez-Sandoval JC
    Clin Nephrol; 2023 May; 99(5):228-236. PubMed ID: 36881881
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
    Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK
    BMJ Open; 2018 Jan; 8(1):e018794. PubMed ID: 29358433
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Autosomal dominant polycystic kidney disease: new role for ultrasound.
    İmamoğlu H; Zararsız G; Doğan S; Koçyiğit İ; Eroğlu E; Öztürk A; Erdoğan N
    Eur Radiol; 2019 Nov; 29(11):5991-5998. PubMed ID: 31028448
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Gray matter segmentation of the spinal cord with active contours in MR images.
    Datta E; Papinutto N; Schlaeger R; Zhu A; Carballido-Gamio J; Henry RG
    Neuroimage; 2017 Feb; 147():788-799. PubMed ID: 27495383
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Abdominal Imaging in ADPKD: Beyond Total Kidney Volume.
    Caroli A; Kline TL
    J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.